Our study aimed to further explore the prevalence and demographics of PD-1 inhibitor-associated neuropathy as it relates to the common risk factors of other neuropathies and compare different PD-1 inhibitors in their rates of PD-1 inhibitor-associated neuropathy. The gene discussed is PDCD1; the disease is neuropathy.